"Name"	"Genes (tot)"	"Stat (dist.dir.up)"	"p (dist.dir.up)"	"p adj (dist.dir.up)"	"Stat (dist.dir.dn)"	"p (dist.dir.dn)"	"p adj (dist.dir.dn)"	"Stat (non-dir.)"	"p (non-dir.)"	"p adj (non-dir.)"	"Genes (up)"	"Stat (mix.dir.up)"	"p (mix.dir.up)"	"p adj (mix.dir.up)"	"Genes (down)"	"Stat (mix.dir.dn)"	"p (mix.dir.dn)"	"p adj (mix.dir.dn)"
"1"	"p53 signaling pathway"	66	0.32912	0.21693	1	-0.32912	0.78475	0.92689	2.7637	0.021521	0.04953	30	3.5671	0.027283	0.20202	36	0.48576	0.11759	0.1784
"2"	"mTOR signaling pathway"	147	-2.2236	0.85151	1	2.2236	0.15173	0.39218	4.9674	8.6874e-05	0.00082399	60	3.9349	0.0492	0.2565	87	3.1892	0.00075991	0.0038822
"3"	"mRNA surveillance pathway"	88	4.2981	3.1086e-05	0.0016216	-4.2981	0.99997	1	1.8086	0.050384	0.088596	55	4.6593	0.01242	0.13903	32	-1.658	0.54279	0.61385
"4"	"cGMP-PKG signaling pathway"	162	-0.68247	0.40275	1	0.68247	0.5996	0.80368	3.5567	0.0015354	0.0065831	78	2.9472	0.25494	0.57453	84	2.0993	0.0035197	0.012036
"5"	"cAMP signaling pathway"	185	-1.4188	0.59565	1	1.4188	0.40718	0.65023	1.298	0.050264	0.088596	79	1.987	0.54917	0.8072	106	-0.00054024	0.061992	0.11162
"6"	"beta-Alanine metabolism"	31	2.8196	0.0050207	0.11225	-2.8196	0.9948	1	1.1516	0.16281	0.22912	18	2.9466	0.072832	0.32785	13	-1.6889	0.66667	0.72275
"7"	"alpha-Linolenic acid metabolism"	22	0.80905	0.18353	1	-0.80905	0.81581	0.95636	-2.567	0.90359	0.93034	9	0.75478	0.47396	0.77431	13	-3.9674	0.95904	0.97471
"8"	"Wnt signaling pathway"	139	-1.732	0.72762	1	1.732	0.27663	0.51539	1.2814	0.068687	0.11256	54	2.4511	0.28066	0.58631	85	-0.31504	0.12386	0.18431
"9"	"Vitamin digestion and absorption"	23	-1.3758	0.78318	1	1.3758	0.21682	0.45067	-1.9927	0.83064	0.85805	8	-0.2731	0.78734	0.92401	15	-2.268	0.78529	0.82231
"10"	"Vitamin B6 metabolism"	8	-0.90961	0.69747	1	0.90961	0.30253	0.54421	1.7527	0.11009	0.16254	5	-0.15238	0.68965	0.87905	3	3.0589	0.020455	0.049315
"11"	"Viral myocarditis"	71	-4.052	0.99665	1	4.052	0.0033702	0.030139	1.7908	0.060337	0.10099	18	1.9813	0.23583	0.56419	53	0.91808	0.042505	0.084198
"12"	"Viral carcinogenesis"	209	-1.1305	0.52875	1	1.1305	0.47498	0.73236	3.7011	0.0011395	0.0056611	91	4.3716	0.045373	0.24756	118	1.0867	0.013785	0.036641
"13"	"Vasopressin-regulated water reabsorption"	42	-0.71122	0.5576	1	0.71122	0.44614	0.6982	2.0352	0.063086	0.10503	19	1.8183	0.2702	0.58121	23	1.0975	0.076266	0.12961
"14"	"Vascular smooth muscle contraction"	122	-0.56922	0.41126	1	0.56922	0.59183	0.80368	3.4952	0.0040529	0.013495	58	2.9083	0.18699	0.51774	64	2.0572	0.0077192	0.02253
"15"	"Valine, leucine and isoleucine degradation"	53	2.465	0.0091409	0.17252	-2.465	0.99096	1	4.2092	0.0020009	0.0077317	29	4.4893	0.0075889	0.10728	24	1.3202	0.06913	0.12216
"16"	"Valine, leucine and isoleucine biosynthesis"	3	0.23624	0.37568	1	-0.23624	0.62432	0.82453	-1.2702	0.75713	0.78994	1	0.45169	0.46581	0.77021	2	-1.875	0.79557	0.82241
"17"	"VEGF signaling pathway"	55	-0.012746	0.30665	1	0.012746	0.69386	0.87652	3.3744	0.0080836	0.023869	28	2.0973	0.25835	0.57586	27	2.6804	0.0089743	0.025843
"18"	"Ubiquitin mediated proteolysis"	136	0.37675	0.15646	1	-0.37675	0.8438	0.96744	4.9326	0.00010424	0.00090313	70	3.692	0.088833	0.36234	66	3.2785	0.0011009	0.0052674
"19"	"Ubiquinone and other terpenoid-quinone biosynthesis"	10	-1.205	0.76827	1	1.205	0.23412	0.4638	2.3369	0.05199	0.090096	4	1.1756	0.2709	0.58121	6	2.0571	0.051574	0.097803
"20"	"Tyrosine metabolism"	37	-1.5634	0.80452	1	1.5634	0.19544	0.42961	-1.2342	0.65706	0.71409	12	0.56437	0.56841	0.8072	25	-1.8925	0.67108	0.72468
"21"	"Type II diabetes mellitus"	45	-3.5045	0.99115	1	3.5045	0.0091168	0.057071	1.0754	0.15498	0.21949	8	2.6624	0.050309	0.2565	37	-0.051993	0.20402	0.26886
"22"	"Type I diabetes mellitus"	53	-3.0692	0.9755	1	3.0692	0.02461	0.11328	-0.40181	0.44436	0.51897	16	-0.4625	0.84809	0.9589	37	-0.17676	0.22535	0.29231
"23"	"Tuberculosis"	159	-4.5344	0.99634	1	4.5344	0.0038955	0.033206	2.6587	0.0095987	0.026421	56	1.0112	0.71339	0.88274	103	2.5577	0.0012496	0.0057149
"24"	"Tryptophan metabolism"	44	-1.6537	0.81227	1	1.6537	0.18878	0.42961	1.9337	0.070603	0.1145	19	1.0608	0.48799	0.77431	25	1.6405	0.057521	0.10648
"25"	"Transcriptional misregulation in cancer"	165	-1.9496	0.77217	1	1.9496	0.23372	0.4638	0.3446	0.18522	0.25206	64	1.6821	0.5559	0.8072	101	-0.89853	0.17319	0.23727
"26"	"Toxoplasmosis"	106	-3.7652	0.98992	1	3.7652	0.010228	0.061564	2.2344	0.028485	0.059046	38	0.82677	0.68298	0.87905	68	2.1717	0.0056509	0.017752
"27"	"Toll-like receptor signaling pathway"	86	-4.1229	0.99578	1	4.1229	0.0045396	0.037392	3.3663	0.0051906	0.016411	29	1.0932	0.55072	0.8072	57	3.3551	0.00089156	0.0044012
"28"	"Tight junction"	160	-2.163	0.80425	1	2.163	0.19724	0.42961	1.961	0.031589	0.064204	70	2.2555	0.40994	0.71624	90	0.62556	0.033199	0.069402
"29"	"Thyroid hormone synthesis"	72	-0.034606	0.31184	1	0.034606	0.69003	0.87652	0.64814	0.20238	0.26955	29	2.2677	0.22473	0.56388	43	-1.0236	0.38218	0.45715
"30"	"Thyroid hormone signaling pathway"	114	-0.47204	0.40115	1	0.47204	0.6002	0.80368	5.1864	0.00010964	0.00090313	55	3.5727	0.077264	0.33844	59	3.7598	0.00037802	0.0025014
"31"	"Thyroid cancer"	28	-1.1224	0.71035	1	1.1224	0.29153	0.53051	2.9214	0.020227	0.047603	11	2.3505	0.11658	0.41202	17	1.8584	0.045737	0.089461
"32"	"Thiamine metabolism"	13	-1.1468	0.74256	1	1.1468	0.25744	0.48835	0.5297	0.29357	0.36609	6	-0.51555	0.79999	0.93183	7	1.1992	0.15213	0.21827
"33"	"Th17 cell differentiation"	97	-2.1881	0.86716	1	2.1881	0.13482	0.37344	1.8669	0.044029	0.080727	33	2.2185	0.25483	0.57453	64	0.70538	0.051945	0.097909
"34"	"Th1 and Th2 cell differentiation"	84	-1.9504	0.8289	1	1.9504	0.17496	0.41174	0.7805	0.16324	0.22912	29	1.5116	0.42567	0.73215	55	-0.1331	0.1579	0.2222
"35"	"Terpenoid backbone biosynthesis"	21	3.2048	0.002406	0.068203	-3.2048	0.99763	1	4.4109	0.0016468	0.0066926	13	4.7271	0.00088789	0.026128	8	1.1205	0.12238	0.18299
"36"	"Taurine and hypotaurine metabolism"	10	3.3601	0.0026279	0.068203	-3.3601	0.99725	1	2.1258	0.067169	0.11065	7	3.3213	0.016587	0.14731	3	-1.1922	0.66698	0.72275
"37"	"Taste transduction"	54	0.082736	0.29017	1	-0.082736	0.70985	0.8923	-5.4163	0.99842	1	22	-0.29796	0.86272	0.9589	32	-6.7889	0.99897	1
"38"	"TNF signaling pathway"	105	-2.2833	0.89247	1	2.2833	0.11095	0.32456	3.176	0.005583	0.017302	38	2.893	0.1215	0.42012	67	1.7971	0.014653	0.038619
"39"	"TGF-beta signaling pathway"	80	1.4864	0.03787	0.47413	-1.4864	0.96113	1	1.0332	0.14711	0.21122	42	2.5304	0.2057	0.54215	38	-1.161	0.40819	0.48086
"40"	"T cell receptor signaling pathway"	100	-2.062	0.84571	1	2.062	0.15986	0.39399	2.2107	0.028364	0.059046	40	1.7092	0.44711	0.75163	60	1.4584	0.0184	0.045763
"41"	"Systemic lupus erythematosus"	120	-5.9451	0.99997	1	5.9451	3.5523e-05	0.00079418	-6.2625	0.99923	1	25	-0.27989	0.87219	0.96188	89	-1.9022	0.37771	0.45355
"42"	"Synthesis and degradation of ketone bodies"	9	0.89614	0.17357	1	-0.89614	0.8272	0.95893	6.1116	5.5152e-05	0.00059526	5	4.3966	0.0010082	0.026128	4	4.2519	0.0034227	0.012036
"43"	"Synaptic vesicle cycle"	59	-0.36353	0.42684	1	0.36353	0.57402	0.80209	-0.29273	0.39394	0.46883	24	1.1727	0.48062	0.77431	35	-1.3511	0.50057	0.57234
"44"	"Sulfur relay system"	7	-1.4862	0.85376	1	1.4862	0.15188	0.39218	0.8919	0.23323	0.30166	2	0.12216	0.54838	0.8072	5	0.97805	0.17783	0.24256
"45"	"Sulfur metabolism"	10	0.053405	0.40583	1	-0.053405	0.59481	0.80368	2.3171	0.053286	0.091268	5	2.1391	0.09512	0.37231	5	1.1378	0.15356	0.21906
"46"	"Steroid hormone biosynthesis"	85	-3.8586	0.99374	1	3.8586	0.0066442	0.04442	0.54017	0.19016	0.25655	26	1.0147	0.54878	0.8072	58	1.0525	0.041471	0.082676
"47"	"Steroid biosynthesis"	18	-0.88408	0.65863	1	0.88408	0.34316	0.57903	2.9898	0.02571	0.057073	9	1.584	0.23528	0.56419	9	2.6442	0.022578	0.052674
"48"	"Starch and sucrose metabolism"	32	-3.933	0.9965	1	3.933	0.0039253	0.033206	3.9389	0.0033596	0.011949	13	-0.32176	0.81232	0.94154	19	5.378	6.2067e-05	0.00068938
"49"	"Staphylococcus aureus infection"	47	-6.4981	1	1	6.4981	7.6554e-07	2.9952e-05	2.5452	0.039098	0.075541	5	-1.1072	0.89377	0.97843	42	3.0745	0.002577	0.0098944
"50"	"Spliceosome"	127	0.86699	0.092136	0.90121	-0.86699	0.90758	1	3.7186	0.003024	0.010879	68	2.8942	0.22845	0.56388	58	3.4468	0.00095604	0.0046457
"51"	"Sphingolipid signaling pathway"	117	-2.362	0.89539	1	2.362	0.10644	0.3143	3.8152	0.0017443	0.0069111	51	1.6742	0.50428	0.7881	66	3.608	0.00057071	0.0033367
"52"	"Sphingolipid metabolism"	44	-0.27511	0.42043	1	0.27511	0.58073	0.80368	0.72086	0.22969	0.29955	21	0.66791	0.62004	0.8404	23	0.35883	0.16358	0.22814
"53"	"Small cell lung cancer"	81	-1.4296	0.70644	1	1.4296	0.29574	0.53507	4.7041	0.00053937	0.0033103	38	2.3753	0.22491	0.56388	43	4.2234	0.000451	0.0027502
"54"	"Signaling pathways regulating pluripotency of stem cells"	133	-0.88893	0.49831	1	0.88893	0.50576	0.75383	1.9131	0.034893	0.0694	58	3.3264	0.11255	0.40559	75	-0.3776	0.13608	0.19962
"55"	"Serotonergic synapse"	122	-2.5254	0.901	1	2.5254	0.10156	0.30567	0.82023	0.14543	0.20977	52	0.12801	0.90314	0.97843	70	0.97251	0.035117	0.072327
"56"	"Selenocompound metabolism"	16	-3.29	0.98846	1	3.29	0.012642	0.069418	3.7934	0.0060966	0.018708	2	3.6438	0.0041284	0.067575	14	2.6781	0.01936	0.047039
"57"	"Salmonella infection"	76	-3.1113	0.97018	1	3.1113	0.031194	0.13448	-0.75338	0.47985	0.54616	23	-0.56042	0.90607	0.97843	53	-0.53297	0.19812	0.26444
"58"	"Salivary secretion"	74	-2.971	0.95159	1	2.971	0.050385	0.18127	0.54092	0.21322	0.28159	27	0.41007	0.74203	0.89139	47	0.36793	0.11162	0.1727
"59"	"SNARE interactions in vesicular transport"	31	1.3566	0.077262	0.78841	-1.3566	0.92214	1	4.0703	0.0027647	0.010302	18	2.9833	0.069045	0.31578	13	2.775	0.016441	0.041912
"60"	"Ribosome biogenesis in eukaryotes"	77	2.5463	0.0028327	0.068203	-2.5463	0.99706	1	1.5936	0.072902	0.11762	45	2.862	0.14565	0.43942	32	-0.92188	0.37487	0.45187
"61"	"Ribosome"	128	-4.3823	0.99674	1	4.3823	0.0032685	0.030139	1.6053	0.0521	0.090096	48	-1.6378	0.99584	1	80	3.2993	0.00076147	0.0038822
"62"	"Riboflavin metabolism"	7	-1.014	0.75163	1	1.014	0.25379	0.48438	3.6036	0.009862	0.026842	3	1.9799	0.096968	0.37231	4	3.0525	0.022224	0.052362
"63"	"Rheumatoid arthritis"	77	-2.9277	0.96497	1	2.9277	0.036669	0.14528	1.0883	0.12466	0.18319	26	1.0216	0.54668	0.8072	51	0.60789	0.074475	0.1278
"64"	"Retrograde endocannabinoid signaling"	133	-1.933	0.79433	1	1.933	0.21063	0.44849	-2.0407	0.71309	0.7566	57	-1.3568	0.9928	1	76	-1.5245	0.34685	0.42302
"65"	"Retinol metabolism"	86	-3.8356	0.99205	1	3.8356	0.0084791	0.054162	3.3894	0.004982	0.015912	24	4.0676	0.0098708	0.12642	61	2.5243	0.0042946	0.014059
"66"	"Renin-angiotensin system"	27	-0.85135	0.62815	1	0.85135	0.37311	0.60825	-4.1595	0.98563	1	8	-1.1461	0.93607	0.98614	19	-4.2148	0.97	0.98264
"67"	"Renin secretion"	65	0.30894	0.23117	1	-0.30894	0.76971	0.92306	0.20186	0.27526	0.3474	35	1.3248	0.52076	0.80576	29	0.37129	0.15987	0.22396
"68"	"Renal cell carcinoma"	63	-0.45444	0.46096	1	0.45444	0.54178	0.78113	2.5838	0.020686	0.04832	28	2.6564	0.13804	0.43942	35	1.0906	0.07479	0.1278
"69"	"Regulation of lipolysis in adipocytes"	52	-0.73891	0.54367	1	0.73891	0.45863	0.71065	1.4354	0.10479	0.15619	22	1.3104	0.44222	0.74864	30	0.7677	0.092923	0.1482
"70"	"Regulation of actin cytoskeleton"	207	-3.3203	0.9514	1	3.3203	0.051512	0.18322	4.2373	0.00032051	0.0021808	82	3.0197	0.24468	0.56784	125	3.0069	0.00018487	0.0014374
"71"	"Ras signaling pathway"	218	-3.5279	0.96561	1	3.5279	0.035306	0.14352	4.9499	9.8751e-05	0.00090313	87	4.0156	0.0646	0.3044	131	3.113	0.00026544	0.0018869
"72"	"Rap1 signaling pathway"	206	-5.7456	0.99986	1	5.7456	0.0001472	0.0028796	7.391	4.1475e-08	1.8545e-06	77	3.4742	0.13669	0.43942	129	6.6558	7.4776e-09	3.8759e-07
"73"	"RNA transport"	161	3.2487	0.00041713	0.013056	-3.2487	0.99959	1	1.8549	0.035067	0.0694	93	3.7838	0.12158	0.42012	67	-0.57965	0.2026	0.26812
"74"	"RNA polymerase"	28	-2.1153	0.90841	1	2.1153	0.09297	0.28812	3.271	0.011861	0.030936	9	2.0312	0.14107	0.43942	19	2.5729	0.015172	0.039322
"75"	"RNA degradation"	75	-1.2088	0.66143	1	1.2088	0.34182	0.57903	1.3207	0.091302	0.14078	34	0.722	0.71528	0.88274	41	1.1288	0.05304	0.09937
"76"	"RIG-I-like receptor signaling pathway"	54	-1.4593	0.75716	1	1.4593	0.24638	0.47899	1.0492	0.14319	0.20845	24	0.47738	0.69133	0.87905	30	0.98061	0.073016	0.12746
"77"	"Pyruvate metabolism"	36	-1.8042	0.85848	1	1.8042	0.1457	0.38647	4.4152	0.0015588	0.0065931	13	3.1313	0.031632	0.21861	23	3.1697	0.0035169	0.012036
"78"	"Pyrimidine metabolism"	100	-4.2498	0.99717	1	4.2498	0.0032427	0.030139	5.1016	0.00012967	0.00098991	32	2.656	0.12485	0.42204	68	4.3646	5.9844e-05	0.00068932
"79"	"Purine metabolism"	173	-3.9896	0.98789	1	3.9896	0.012425	0.069418	6.142	4.8551e-06	0.00010855	67	3.1773	0.17874	0.50997	106	5.3205	1.4365e-06	3.7229e-05
"80"	"Proximal tubule bicarbonate reclamation"	21	-2.2259	0.92381	1	2.2259	0.075968	0.24263	1.8988	0.0764	0.12201	6	1.1927	0.2836	0.58631	15	1.4923	0.059333	0.10861
"81"	"Proteoglycans in cancer"	197	-1.1115	0.51111	1	1.1115	0.49252	0.74834	5.9784	9.8246e-06	0.00019219	88	5.0066	0.012517	0.13903	109	3.5386	0.0001373	0.001111
"82"	"Protein processing in endoplasmic reticulum"	157	4.807	1.5505e-06	0.00016177	-4.807	1	1	4.1245	0.00087768	0.0046562	96	5.3147	0.0071438	0.1058	61	-0.050286	0.13304	0.19609
"83"	"Protein export"	25	2.4045	0.012515	0.21762	-2.4045	0.98708	1	0.77343	0.23309	0.30166	17	1.4222	0.3555	0.66713	8	-0.70598	0.48298	0.55427
"84"	"Protein digestion and absorption"	85	-1.667	0.78193	1	1.667	0.22155	0.45325	-3.5264	0.95294	0.97793	32	-0.73067	0.95016	0.99161	53	-3.898	0.88068	0.90393
"85"	"Proteasome"	45	-3.3092	0.98673	1	3.3092	0.013638	0.073601	6.1682	2.2462e-05	0.00029113	17	3.6414	0.016995	0.14731	28	4.9822	9.6457e-05	0.0009653
"86"	"Prostate cancer"	85	-1.2305	0.66874	1	1.2305	0.33486	0.57705	4.9826	0.00012391	0.00098991	38	2.9925	0.10627	0.40304	47	4.0099	0.00043365	0.0026973
"87"	"Propanoate metabolism"	30	2.3053	0.017334	0.24661	-2.3053	0.98261	1	4.6686	0.00087397	0.0046562	17	4.9618	0.0007854	0.026128	13	1.4181	0.087857	0.14306
"88"	"Prolactin signaling pathway"	67	-2.0571	0.87696	1	2.0571	0.12663	0.35389	2.5158	0.024429	0.055408	21	4.0263	0.014025	0.1409	46	0.31577	0.11487	0.17598
"89"	"Progesterone-mediated oocyte maturation"	81	-1.7056	0.77461	1	1.7056	0.22754	0.46032	2.1168	0.041137	0.077566	33	1.756	0.38333	0.69718	48	1.2938	0.037495	0.07572
"90"	"Prion diseases"	33	-4.6502	0.99943	1	4.6502	0.00059804	0.0097767	2.7236	0.02836	0.059046	8	-0.11732	0.74786	0.89403	25	3.1956	0.006859	0.020316
"91"	"Primary immunodeficiency"	34	-1.9968	0.88175	1	1.9968	0.11987	0.34274	1.6738	0.095716	0.14543	13	0.50916	0.58949	0.81642	21	1.7292	0.044677	0.087941
"92"	"Primary bile acid biosynthesis"	15	2.4396	0.017095	0.24661	-2.4396	0.9832	1	2.826	0.026186	0.057086	9	3.2339	0.021311	0.17441	6	0.50751	0.23976	0.30812
"93"	"Porphyrin and chlorophyll metabolism"	40	-1.7708	0.85982	1	1.7708	0.14006	0.38065	0.77468	0.18413	0.25191	9	3.509	0.012379	0.13903	30	0.47139	0.12693	0.18797
"94"	"Platinum drug resistance"	75	-6.656	1	1	8.1645	5.7842e-09	3.6209e-07	7.5617	1.1518e-07	4.5065e-06	28	0.82018	0.63991	0.86152	47	8.9191	3.2522e-10	3.3714e-08
"95"	"Platelet activation"	119	-2.5374	0.91795	1	2.5374	0.084966	0.26594	3.7851	0.0021526	0.0081175	54	1.1444	0.67032	0.87655	65	4.0784	0.00013111	0.001102
"96"	"Phototransduction"	25	-1.315	0.76531	1	1.315	0.23759	0.46771	-1.4915	0.72599	0.7651	8	0.17331	0.66506	0.87655	17	-1.9275	0.69644	0.74155
"97"	"Phosphonate and phosphinate metabolism"	5	1.6581	0.078085	0.78841	-1.6581	0.92191	1	1.6592	0.12643	0.18492	3	2.2188	0.067583	0.31371	2	-0.093923	0.41355	0.48534
"98"	"Phospholipase D signaling pathway"	141	-2.394	0.87761	1	2.394	0.1239	0.34939	1.7212	0.047499	0.085443	59	1.4366	0.59934	0.82113	82	1.0384	0.025806	0.059012
"99"	"Phosphatidylinositol signaling system"	94	-3.9166	0.99294	1	3.9166	0.0073933	0.04821	4.4494	0.00083101	0.0045633	34	1.9634	0.34139	0.65538	60	4.0911	0.00010809	0.0009653
"100"	"Phenylalanine, tyrosine and tryptophan biosynthesis"	6	1.0819	0.16941	1	-1.0819	0.82637	0.95893	-0.60319	0.61656	0.67363	3	0.6589	0.41271	0.71706	3	-1.5119	0.73165	0.77395
"101"	"Phenylalanine metabolism"	21	0.77236	0.17996	1	-0.77236	0.82055	0.95833	-0.46003	0.49497	0.5593	8	2.2936	0.090876	0.36234	13	-2.3839	0.79673	0.82241
"102"	"Phagosome"	161	-4.8795	0.99879	1	4.8795	0.0012514	0.01632	4.7587	0.0001969	0.0014007	59	1.9279	0.44293	0.74864	102	4.5123	1.3855e-05	0.00019719
"103"	"Pertussis"	71	-3.267	0.98143	1	3.267	0.018669	0.0899	2.4028	0.027506	0.058568	24	1.1691	0.48175	0.77431	47	2.1178	0.012777	0.03506
"104"	"Peroxisome"	82	4.2499	5.2648e-05	0.0023541	-4.2499	0.99995	1	8.5006	3.3278e-08	1.736e-06	54	6.6795	5.0753e-05	0.0039461	28	5.2711	4.8511e-05	0.00058027
"105"	"Pentose phosphate pathway"	29	-3.328	0.98534	1	3.328	0.015277	0.078956	1.7745	0.08076	0.12831	12	-0.82578	0.89403	0.97843	17	3.0114	0.0091811	0.026196
"106"	"Pentose and glucuronate interconversions"	33	-4.4914	0.99912	1	4.4914	0.00091691	0.012478	-0.38447	0.48367	0.5485	4	-0.35541	0.7028	0.87905	28	1.2684	0.061155	0.11122
"107"	"Pathways in cancer"	382	-3.4137	0.93853	1	3.4137	0.063545	0.21619	3.9807	0.00042655	0.0026702	160	3.0013	0.48519	0.77431	222	2.6738	0.00010367	0.0009653
"108"	"Parkinson disease"	123	-4.3746	0.99754	1	4.3746	0.0025589	0.027083	3.0168	0.0090507	0.025521	50	-0.34631	0.93858	0.98614	73	4.2026	8.2197e-05	0.00088149
"109"	"Pantothenate and CoA biosynthesis"	17	2.2232	0.024283	0.32642	-2.2232	0.97637	1	1.1562	0.18996	0.25655	12	1.5677	0.27285	0.58121	5	-0.29679	0.4425	0.5135
"110"	"Pancreatic secretion"	93	-1.5235	0.72158	1	1.5235	0.2825	0.52321	-4.0793	0.9763	0.99864	35	-0.23084	0.91617	0.98252	57	-3.9424	0.88476	0.90514
"111"	"Pancreatic cancer"	63	-1.6557	0.80513	1	1.6557	0.19765	0.42961	3.759	0.0028979	0.010671	25	2.5997	0.11346	0.40559	38	2.7314	0.0051114	0.016347
"112"	"PPAR signaling pathway"	79	6.0236	6.0044e-08	9.397e-06	-6.0236	1	1	8.2728	1.4563e-08	9.1164e-07	47	9.2698	6.3612e-10	9.8917e-08	32	1.7641	0.030386	0.065173
"113"	"PI3K-Akt signaling pathway"	317	-3.3863	0.94791	1	3.3863	0.053015	0.18645	9.2364	1.3403e-10	2.0975e-08	140	5.8706	0.010162	0.12642	177	7.1397	1.1498e-10	1.788e-08
"114"	"Oxytocin signaling pathway"	146	-0.14077	0.23862	1	0.14077	0.76217	0.91753	2.2343	0.02098	0.048643	69	3.3284	0.13714	0.43942	76	0.86704	0.036819	0.075333
"115"	"Oxidative phosphorylation"	113	-3.7984	0.98967	1	3.7984	0.011213	0.064992	0.69915	0.14914	0.21219	46	-2.0757	0.99798	1	67	2.6279	0.0040228	0.013318
"116"	"Ovarian steroidogenesis"	52	-0.07295	0.33713	1	0.07295	0.66363	0.85833	0.033333	0.33679	0.41177	20	2.4054	0.14445	0.43942	32	-1.8592	0.58864	0.64917
"117"	"Other types of O-glycan biosynthesis"	21	-1.3431	0.77042	1	1.3431	0.22942	0.46032	1.6493	0.1003	0.15021	8	2.1435	0.11301	0.40559	12	2.8016	0.014811	0.038708
"118"	"Other glycan degradation"	15	-2.9959	0.98424	1	2.9959	0.015588	0.078956	3.9984	0.0040463	0.013495	6	0.56658	0.47848	0.77431	9	4.6993	0.00063871	0.0034078
"119"	"Osteoclast differentiation"	120	-4.6479	0.99863	1	4.6479	0.0015083	0.018884	5.0404	0.00012865	0.00098991	41	2.2386	0.27187	0.58121	79	4.5994	3.5304e-05	0.00045748
"120"	"Oocyte meiosis"	107	0.15117	0.22498	1	-0.15117	0.77583	0.92472	3.3563	0.005367	0.016799	51	3.5	0.073792	0.32785	56	1.2993	0.03025	0.065173
"121"	"One carbon pool by folate"	18	-1.4122	0.78985	1	1.4122	0.21211	0.44859	2.104	0.074517	0.11961	6	1.6346	0.17416	0.5015	12	1.421	0.087841	0.14306
"122"	"Olfactory transduction"	656	3.2482	1.5719e-05	0.00098401	-3.2482	0.99998	1	-22.151	1	1	294	-2.7924	1	1	362	-27.302	1	1
"123"	"Nucleotide excision repair"	42	-2.9011	0.96693	1	2.9011	0.034917	0.14352	5.0622	0.00056602	0.003407	17	2.0739	0.18826	0.51774	25	4.8512	0.00032406	0.0022073
"124"	"Notch signaling pathway"	48	-1.9723	0.86407	1	1.9723	0.14107	0.38065	0.88695	0.17355	0.24143	20	-0.11125	0.8211	0.94578	28	1.2553	0.06209	0.11162
"125"	"Non-small cell lung cancer"	57	-1.9057	0.84566	1	1.9057	0.15418	0.39218	3.3963	0.0076622	0.02306	24	1.5817	0.35526	0.66713	33	3.1147	0.0037188	0.012571
"126"	"Non-homologous end-joining"	11	0.034024	0.39962	1	-0.034024	0.60083	0.80368	1.7833	0.097635	0.14692	6	0.77862	0.40925	0.71624	5	1.7921	0.077638	0.13123
"127"	"Non-alcoholic fatty liver disease (NAFLD)"	139	-3.6906	0.98454	1	3.6906	0.016538	0.080883	2.3382	0.016173	0.039549	59	-0.48865	0.96408	0.99349	80	3.5017	0.00050744	0.0030349
"128"	"Nitrogen metabolism"	16	-2.2114	0.92501	1	2.2114	0.078477	0.24811	-1.0595	0.67143	0.72719	5	-2.2335	0.98358	0.99965	11	0.22807	0.26633	0.33534
"129"	"Nicotine addiction"	35	0.26272	0.28508	1	-0.26272	0.71505	0.89519	-5.0756	0.99595	1	15	-1.4335	0.95977	0.99349	20	-5.473	0.99396	1
"130"	"Nicotinate and nicotinamide metabolism"	32	-1.9964	0.88351	1	1.9964	0.12045	0.34274	0.18554	0.33662	0.41177	13	-0.82536	0.90089	0.97843	19	0.9235	0.11854	0.17896
"131"	"Neurotrophin signaling pathway"	118	-0.78621	0.50556	1	0.78621	0.49814	0.75147	3.9487	0.0014088	0.0063727	53	3.4651	0.086008	0.36234	65	2.1914	0.0058769	0.018277
"132"	"Neuroactive ligand-receptor interaction"	238	-1.0328	0.43737	1	1.0328	0.56701	0.79943	-8.0829	0.99994	1	89	0.46608	0.91335	0.98252	149	-10.576	1	1
"133"	"Neomycin, kanamycin and gentamicin biosynthesis"	4	-2.5185	0.9726	1	2.5185	0.027399	0.12251	1.2328	0.1825	0.25165	0	NA	NA	NA	4	1.2328	0.16948	0.23426
"134"	"Natural killer cell mediated cytotoxicity"	99	-5.1799	0.99971	1	5.1799	0.00031535	0.0054835	2.356	0.026517	0.05724	32	-0.080739	0.8664	0.9589	67	2.9197	0.0024351	0.0095789
"135"	"NOD-like receptor signaling pathway"	150	-6.182	0.99998	1	6.182	1.8374e-05	0.00051179	4.8805	0.00016836	0.0012255	50	1.2533	0.62152	0.8404	100	5.0911	3.5331e-06	7.3254e-05
"136"	"NF-kappa B signaling pathway"	93	-2.7038	0.93404	1	2.7038	0.068619	0.22142	2.7212	0.013112	0.033366	35	1.7855	0.36649	0.67844	58	2.0587	0.010458	0.029569
"137"	"N-Glycan biosynthesis"	48	-0.54904	0.50365	1	0.54904	0.49938	0.75147	-0.10627	0.37022	0.4474	22	0.99443	0.53897	0.8072	25	0.5618	0.16864	0.23414
"138"	"Mucin type O-glycan biosynthesis"	26	-1.3485	0.78271	1	1.3485	0.21741	0.45067	-1.373	0.69326	0.74058	6	0.94715	0.35609	0.66713	20	-2.0843	0.69863	0.74155
"139"	"Morphine addiction"	87	-0.26045	0.35204	1	0.26045	0.64986	0.84789	-0.91145	0.51914	0.5824	41	0.39569	0.7985	0.93183	46	-1.627	0.47807	0.55066
"140"	"Mitophagy - animal"	61	-1.0536	0.63628	1	1.0536	0.36546	0.59962	4.4902	0.00072627	0.0041331	26	3.4038	0.043354	0.24077	35	2.9941	0.0051512	0.016347
"141"	"Mismatch repair"	21	-3.6394	0.99442	1	3.6394	0.0055321	0.038479	3.2361	0.012769	0.032761	7	0.014653	0.7038	0.87905	14	3.9531	0.002464	0.0095789
"142"	"Mineral absorption"	42	-0.94103	0.62646	1	0.94103	0.37772	0.61258	0.2804	0.29849	0.37074	18	0.48501	0.6627	0.87655	24	-0.0491	0.24118	0.30867
"143"	"MicroRNAs in cancer"	139	-4.1278	0.99387	1	4.1278	0.0066701	0.04442	5.0505	6.6764e-05	0.0006741	52	2.2892	0.32948	0.64655	87	4.6141	3.3297e-05	0.00045023
"144"	"Metabolism of xenobiotics by cytochrome P450"	63	-7.938	1	1	9.5971	3.9335e-13	1.2312e-10	4.3429	0.00091514	0.004774	14	0.56563	0.59252	0.81642	48	5.8548	5.4987e-06	9.3648e-05
"145"	"Metabolic pathways"	1265	-5.4808	0.98535	1	5.4808	0.016256	0.080763	11.659	0	0	541	9.9182	0.00012227	0.0076055	722	7.4577	0	0
"146"	"Melanoma"	67	0.36479	0.20835	1	-0.36479	0.79067	0.93037	4.2394	0.0013178	0.0061565	31	4.6283	0.0038202	0.066005	36	1.4885	0.037391	0.07572
"147"	"Melanogenesis"	96	-0.51697	0.42938	1	0.51697	0.5732	0.80209	1.6755	0.05505	0.093646	41	2.833	0.1417	0.43942	55	-0.23248	0.17265	0.23727
"148"	"Measles"	121	-4.9308	0.9994	1	4.9308	0.00065595	0.0097767	2.6714	0.014097	0.035298	43	0.5149	0.81439	0.94154	78	2.945	0.0018092	0.0076397
"149"	"Maturity onset diabetes of the young"	19	-0.84927	0.6634	1	0.84927	0.3367	0.57705	-1.5524	0.73176	0.76602	6	-0.13834	0.70174	0.87905	13	-1.7828	0.68605	0.7332
"150"	"Mannose type O-glycan biosynthesis"	22	-1.3876	0.7846	1	1.3876	0.21721	0.45067	-0.51757	0.5324	0.59303	6	1.5052	0.20304	0.5397	16	-1.5287	0.61786	0.679
"151"	"Malaria"	46	-1.8373	0.84798	1	1.8373	0.15537	0.39218	2.4828	0.032526	0.065681	19	1.6601	0.31186	0.62172	27	1.8482	0.030353	0.065173
"152"	"MAPK signaling pathway"	246	-2.4157	0.84365	1	2.4157	0.15937	0.39399	3.5242	0.0011788	0.0057652	107	3.0204	0.33055	0.64655	138	2.7446	0.00040631	0.0025788
"153"	"Lysosome"	120	-7.3351	1	1	7.3351	2.1917e-07	9.7999e-06	5.8483	1.7176e-05	0.00024437	35	0.93156	0.65087	0.86876	85	6.351	2.1937e-07	9.7465e-06
"154"	"Lysine degradation"	56	-0.5558	0.48888	1	0.5558	0.51208	0.75614	3.169	0.0080245	0.023869	30	0.98819	0.56688	0.8072	26	3.5893	0.0018424	0.0076397
"155"	"Lysine biosynthesis"	1	1.5333	0.1082	0.96758	-1.5333	0.8918	0.99766	1.1493	0.2212	0.28969	1	1.1493	0.25925	0.57586	0	NA	NA	NA
"156"	"Longevity regulating pathway - multiple species"	60	-0.5839	0.48204	1	0.5839	0.51939	0.75614	3.1439	0.0096231	0.026421	30	1.891	0.28656	0.58631	30	2.5552	0.0077515	0.02253
"157"	"Longevity regulating pathway"	88	-1.1861	0.61568	1	1.1861	0.38769	0.62229	4.0194	0.0013511	0.0062192	40	2.6828	0.18978	0.51774	48	2.9932	0.0029325	0.010605
"158"	"Long-term potentiation"	63	1.8794	0.025029	0.32642	-1.8794	0.97502	1	2.0368	0.044103	0.080727	37	2.0112	0.32586	0.6455	26	0.77125	0.11257	0.17332
"159"	"Long-term depression"	57	0.25806	0.26286	1	-0.25806	0.73799	0.89879	0.77257	0.19764	0.26436	33	0.10576	0.84066	0.95767	24	1.0666	0.090471	0.14654
"160"	"Lipoic acid metabolism"	2	-0.15369	0.50983	1	0.15369	0.49017	0.74834	0.34988	0.3755	0.45032	1	0.089443	0.58117	0.81642	1	0.40536	0.34659	0.42302
"161"	"Linoleic acid metabolism"	46	-0.99942	0.6514	1	0.99942	0.35185	0.58893	-1.1607	0.61767	0.67363	20	0.065579	0.78243	0.92172	26	-1.6013	0.58345	0.64805
"162"	"Leukocyte transendothelial migration"	107	-4.0262	0.99482	1	4.0262	0.0052742	0.038479	3.5974	0.0035099	0.012073	38	2.0883	0.29894	0.60286	69	2.93	0.0019628	0.0079278
"163"	"Leishmaniasis"	64	-4.0422	0.99592	1	4.0422	0.0049647	0.038479	1.9139	0.058023	0.097641	17	0.39792	0.66897	0.87655	47	1.994	0.015343	0.039435
"164"	"Legionellosis"	56	-1.6659	0.80179	1	1.6659	0.19914	0.42988	0.68905	0.19125	0.25691	23	0.31021	0.73279	0.89139	33	0.63863	0.10665	0.16667
"165"	"Jak-STAT signaling pathway"	133	-4.9074	0.99925	1	4.9074	0.00085541	0.01217	2.8808	0.0083159	0.024165	44	1.3821	0.56119	0.8072	89	2.5498	0.0017315	0.0074791
"166"	"Intestinal immune network for IgA production"	40	-2.8436	0.97442	1	2.8436	0.025479	0.11558	0.30625	0.27231	0.3458	10	0.54451	0.56464	0.8072	30	0.039257	0.19059	0.25634
"167"	"Insulin signaling pathway"	136	-2.0374	0.81522	1	2.0374	0.189	0.42961	5.3386	3.745e-05	0.00043415	58	4.0758	0.036424	0.22639	78	3.5347	0.00060066	0.0033367
"168"	"Insulin secretion"	80	0.62477	0.13859	1	-0.62477	0.86026	0.97579	-0.54495	0.45671	0.52752	37	1.1932	0.56664	0.8072	43	-1.8501	0.56982	0.63517
"169"	"Insulin resistance"	106	-1.6288	0.73969	1	1.6288	0.26188	0.49378	5.8647	2.3254e-05	0.00029113	47	3.9761	0.02954	0.20879	59	4.3121	0.00010936	0.0009653
"170"	"Inositol phosphate metabolism"	69	-2.3234	0.90402	1	2.3234	0.097959	0.29768	4.2863	0.0010168	0.0051333	28	2.1648	0.24144	0.56784	41	3.7715	0.0006465	0.0034078
"171"	"Influenza A"	150	-4.5487	0.99775	1	4.5487	0.0023232	0.02597	2.8042	0.0091373	0.025535	49	2.1202	0.35448	0.66713	101	1.9406	0.0048333	0.015658
"172"	"Inflammatory mediator regulation of TRP channels"	118	-0.22661	0.33962	1	0.22661	0.66294	0.85833	3.7312	0.0021424	0.0081175	51	4.1202	0.025967	0.2019	67	1.3569	0.026812	0.060423
"173"	"Inflammatory bowel disease (IBD)"	55	-2.6415	0.94621	1	2.6415	0.056219	0.19552	0.2747	0.28929	0.36365	17	0.81495	0.54311	0.8072	38	-0.2146	0.2118	0.27793
"174"	"IL-17 signaling pathway"	84	-0.5801	0.45366	1	0.5801	0.54979	0.78578	-0.28345	0.36923	0.4474	35	1.6974	0.39515	0.7097	49	-1.8056	0.5231	0.59591
"175"	"Hypertrophic cardiomyopathy (HCM)"	81	4.8925	8.8076e-06	0.0006892	-4.8925	0.99999	1	2.4108	0.027959	0.059046	50	5.5854	0.001219	0.029163	30	-1.7505	0.58828	0.64917
"176"	"Huntingtons disease"	178	-4.3109	0.99517	1	4.3109	0.0055109	0.038479	2.1557	0.01903	0.045468	74	-1.123	0.99445	1	104	3.7675	0.00010314	0.0009653
"177"	"Homologous recombination"	37	-1.4472	0.77887	1	1.4472	0.22111	0.45325	2.2463	0.047099	0.085213	19	-0.23161	0.83224	0.95481	18	3.4586	0.0027924	0.010339
"178"	"Histidine metabolism"	24	-0.35161	0.48314	1	0.35161	0.5171	0.75614	-0.82077	0.59703	0.65569	8	1.0004	0.39707	0.7097	16	-1.7127	0.65769	0.72022
"179"	"Hippo signaling pathway -multiple species"	25	-1.5853	0.8261	1	1.5853	0.17673	0.4128	0.56115	0.27289	0.3458	11	-0.60065	0.85447	0.9589	14	1.2823	0.10528	0.16536
"180"	"Hippo signaling pathway"	150	-0.18989	0.26737	1	0.18989	0.73543	0.89879	2.4946	0.014727	0.036585	68	3.7108	0.087697	0.36234	82	-0.0052565	0.091196	0.14686
"181"	"Herpes simplex infection"	184	-4.8333	0.99851	1	4.8333	0.0016041	0.019277	3.7052	0.0012192	0.0057821	63	2.714	0.2281	0.56388	120	3.371	0.00039218	0.002541
"182"	"Hepatitis C"	116	-2.1321	0.84441	1	2.1321	0.15841	0.39399	4.0699	0.0016678	0.0066926	52	2.2716	0.33463	0.65044	64	3.4317	0.00061695	0.0033662
"183"	"Hepatitis B"	130	-2.2355	0.8599	1	2.2355	0.14234	0.38078	5.1529	7.027e-05	0.00068733	49	4.356	0.015907	0.14731	81	3.1399	0.00060082	0.0033367
"184"	"Hematopoietic cell lineage"	88	-2.7638	0.93709	1	2.7638	0.065057	0.21852	1.7239	0.056019	0.094778	29	1.0893	0.55188	0.8072	59	1.3417	0.026656	0.060423
"185"	"Hedgehog signaling pathway"	43	-1.8439	0.8373	1	1.8439	0.16348	0.39977	5.0215	0.00041552	0.0026542	16	3.2785	0.037125	0.22639	27	3.8133	0.001202	0.0055795
"186"	"HTLV-I infection"	264	-4.2513	0.99095	1	4.2513	0.0094405	0.057939	5.3675	1.6203e-05	0.00024437	103	3.5122	0.18738	0.51774	161	4.064	1.3949e-05	0.00019719
"187"	"HIF-1 signaling pathway"	98	-0.86162	0.54921	1	0.86162	0.45332	0.70592	4.9968	0.0002076	0.001444	38	5.3237	0.00096448	0.026128	60	2.1493	0.0060223	0.018544
"188"	"Graft-versus-host disease"	49	-3.9017	0.99682	1	3.9017	0.003146	0.030139	-1.599	0.7291	0.7658	11	-1.2321	0.93783	0.98614	38	-1.1528	0.40626	0.48041
"189"	"GnRH signaling pathway"	85	-0.6295	0.48611	1	0.6295	0.51679	0.75614	2.4654	0.018526	0.044606	36	2.8324	0.13129	0.43438	49	0.81931	0.067774	0.12114
"190"	"Glyoxylate and dicarboxylate metabolism"	28	-0.37078	0.4866	1	0.37078	0.51471	0.75614	1.8192	0.083938	0.13202	15	0.68889	0.53821	0.8072	13	1.9299	0.049671	0.095949
"191"	"Glycosylphosphatidylinositol (GPI)-anchor biosynthesis"	23	0.46765	0.26459	1	-0.46765	0.73541	0.89879	-0.28804	0.47708	0.54498	11	0.72727	0.51765	0.80495	12	-1.0951	0.55645	0.62475
"192"	"Glycosphingolipid biosynthesis - lacto and neolacto series"	26	0.17145	0.35006	1	-0.17145	0.65014	0.84789	0.081834	0.37338	0.44949	11	2.1812	0.14384	0.43942	15	-1.7601	0.68179	0.7332
"193"	"Glycosphingolipid biosynthesis - globo and isoglobo series"	15	-0.70342	0.63693	1	0.70342	0.36323	0.59962	0.02079	0.40292	0.47591	6	0.72645	0.42611	0.73215	9	-0.56631	0.45993	0.53174
"194"	"Glycosphingolipid biosynthesis - ganglio series"	14	-0.33171	0.50918	1	0.33171	0.49228	0.74834	1.8902	0.095208	0.14537	5	2.9227	0.026988	0.20202	9	0.17907	0.2938	0.36258
"195"	"Glycosaminoglycan degradation"	18	-1.0076	0.69204	1	1.0076	0.30984	0.55102	0.49304	0.29993	0.37106	8	0.3177	0.62032	0.8404	10	0.37732	0.23343	0.30123
"196"	"Glycosaminoglycan biosynthesis - keratan sulfate"	12	-1.3459	0.81067	1	1.3459	0.19228	0.42961	1.9098	0.094961	0.14537	4	1.059	0.30046	0.60286	8	1.5901	0.073359	0.12746
"197"	"Glycosaminoglycan biosynthesis - heparan sulfate / heparin"	23	0.67258	0.21587	1	-0.67258	0.78413	0.92689	-0.21365	0.45948	0.52752	11	1.6854	0.24649	0.56784	12	-1.9094	0.73441	0.77425
"198"	"Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate"	19	1.0544	0.1415	1	-1.0544	0.85883	0.97579	1.7414	0.096865	0.14647	11	1.7359	0.23453	0.56419	8	0.64819	0.19123	0.25634
"199"	"Glycolysis / Gluconeogenesis"	62	-1.5514	0.75918	1	1.5514	0.2421	0.4736	1.9825	0.049313	0.0882	28	0.97851	0.59228	0.81642	34	1.7891	0.024866	0.057283
"200"	"Glycine, serine and threonine metabolism"	39	-1.6817	0.81276	1	1.6817	0.18977	0.42961	3.7345	0.0042446	0.013839	19	1.4344	0.37556	0.69112	20	3.8169	0.0016198	0.0070953
"201"	"Glycerophospholipid metabolism"	90	1.1692	0.064467	0.7351	-1.1692	0.93536	1	2.9156	0.011559	0.030403	43	4.2107	0.019452	0.1635	47	0.0070101	0.15657	0.22134
"202"	"Glycerolipid metabolism"	56	-0.029971	0.32897	1	0.029971	0.67174	0.86466	2.0801	0.041453	0.077694	21	3.922	0.017052	0.14731	35	-0.4068	0.28896	0.35803
"203"	"Glutathione metabolism"	55	-6.9241	1	1	8.6857	7.6483e-11	5.9848e-09	7.6522	3.5653e-07	1.2399e-05	18	1.3492	0.4058	0.71624	37	8.3886	3.9175e-09	2.4367e-07
"204"	"Glutamatergic synapse"	110	-0.7206	0.45823	1	0.7206	0.54404	0.78113	0.10609	0.27009	0.34505	51	0.36947	0.8539	0.9589	59	-0.19865	0.15442	0.21928
"205"	"Glucagon signaling pathway"	95	0.043182	0.26481	1	-0.043182	0.73548	0.89879	4.2189	0.0012163	0.0057821	50	2.7018	0.20971	0.5435	45	3.282	0.0018784	0.0076865
"206"	"Glioma"	62	0.19358	0.25056	1	-0.19358	0.75045	0.90691	4.829	0.00037813	0.0024657	28	4.7145	0.0033497	0.061281	34	2.2427	0.012683	0.03506
"207"	"Gastric acid secretion"	70	-2.8551	0.96086	1	2.8551	0.039766	0.15558	0.50502	0.22095	0.28969	22	1.2365	0.46475	0.77021	48	-0.22723	0.18191	0.24598
"208"	"Gap junction"	84	-2.363	0.89813	1	2.363	0.10493	0.31278	1.819	0.053361	0.091268	35	0.78701	0.69534	0.87905	49	1.7164	0.021563	0.051191
"209"	"Galactose metabolism"	31	-3.2533	0.98617	1	3.2533	0.014571	0.077302	1.7847	0.0851	0.13318	9	0.51107	0.55075	0.8072	22	1.7916	0.041055	0.082375
"210"	"GABAergic synapse"	83	-1.5472	0.75196	1	1.5472	0.25167	0.48326	-0.62745	0.45741	0.52752	33	0.57939	0.73428	0.89139	50	-1.2791	0.39237	0.46671
"211"	"Fructose and mannose metabolism"	34	-1.517	0.79407	1	1.517	0.20773	0.44534	2.7502	0.025198	0.056335	14	1.5671	0.29135	0.59222	20	2.2747	0.020744	0.049625
"212"	"FoxO signaling pathway"	128	-0.58785	0.4154	1	0.58785	0.58592	0.80368	3.8323	0.00145	0.0063727	63	2.5077	0.2818	0.58631	65	2.909	0.0015919	0.0070727
"213"	"Folate biosynthesis"	12	-2.5918	0.96883	1	2.5918	0.032517	0.13754	2.2551	0.064813	0.10733	2	2.3375	0.05299	0.2575	10	1.425	0.086571	0.14306
"214"	"Focal adhesion"	196	-3.4843	0.96779	1	3.4843	0.034159	0.14256	5.9425	7.384e-06	0.00015408	83	3.5474	0.12903	0.4315	113	4.786	2.816e-06	6.2555e-05
"215"	"Fluid shear stress and atherosclerosis"	138	-4.962	0.99939	1	6.0741	2.1256e-05	0.00051179	8.6997	1.8554e-09	1.9358e-07	56	4.0884	0.033779	0.21886	82	7.9074	1.1134e-09	8.6567e-08
"216"	"Ferroptosis"	38	0.69562	0.16522	1	-0.69562	0.83437	0.96014	4.3254	0.0016433	0.0066926	20	3.1469	0.050095	0.2565	18	2.9675	0.0067508	0.020188
"217"	"Fc gamma R-mediated phagocytosis"	84	-5.2463	0.99978	1	5.2463	0.00024684	0.0045447	5.5005	5.8312e-05	0.00060838	24	2.0428	0.23125	0.56419	60	5.2162	5.7213e-06	9.3648e-05
"218"	"Fc epsilon RI signaling pathway"	63	-4.0006	0.99684	1	4.0006	0.0033213	0.030139	2.4265	0.02598	0.057086	17	1.687	0.2812	0.58631	46	1.8141	0.018541	0.045763
"219"	"Fatty acid metabolism"	51	2.5217	0.0093699	0.17252	-2.5217	0.99018	1	7.135	1.4191e-06	4.038e-05	24	7.8249	5.9878e-08	6.2073e-06	27	2.4288	0.01327	0.035576
"220"	"Fatty acid elongation"	26	1.2572	0.11153	0.96969	-1.2572	0.88859	0.99766	2.9072	0.026744	0.057335	15	2.3837	0.11058	0.40559	11	1.6859	0.074752	0.1278
"221"	"Fatty acid degradation"	47	7.0306	6.9405e-10	2.1724e-07	-7.0306	1	1	9.5141	7.2078e-09	5.6401e-07	30	10.319	7.0277e-14	2.1856e-11	17	2.1118	0.033251	0.069402
"222"	"Fatty acid biosynthesis"	12	-2.3638	0.9539	1	2.3638	0.047806	0.18028	1.4552	0.14886	0.21219	4	0.46546	0.46807	0.77021	8	1.4531	0.085785	0.14267
"223"	"Fat digestion and absorption"	36	0.9762	0.13592	1	-0.9762	0.8635	0.97579	-1.936	0.79659	0.8256	18	0.75909	0.58359	0.81642	18	-3.497	0.9321	0.95043
"224"	"Fanconi anemia pathway"	48	-0.22725	0.40625	1	0.22725	0.59533	0.80368	0.7025	0.20408	0.27066	23	0.27353	0.74234	0.89139	25	0.71105	0.14805	0.21415
"225"	"Ether lipid metabolism"	41	1.4641	0.06576	0.7351	-1.4641	0.93396	1	-0.97028	0.5948	0.65553	23	0.79958	0.59105	0.81642	18	-2.3682	0.78809	0.82241
"226"	"Estrogen signaling pathway"	94	-1.0558	0.56875	1	1.0558	0.43388	0.68243	3.0168	0.010925	0.029227	43	2.3359	0.2864	0.58631	51	1.9508	0.012964	0.03506
"227"	"ErbB signaling pathway"	84	0.2434	0.22447	1	-0.2434	0.777	0.92472	3.6873	0.0029804	0.010847	34	5.0324	0.002361	0.045893	50	0.62953	0.081116	0.13636
"228"	"Epstein-Barr virus infection"	199	-3.0434	0.93881	1	3.0434	0.062791	0.21597	5.6696	1.4405e-05	0.00024437	77	4.4728	0.028037	0.20278	122	3.6877	0.00011174	0.0009653
"229"	"Endometrial cancer"	49	-3.0127	0.97842	1	3.0127	0.021443	0.10169	3.5734	0.0066022	0.020063	17	1.4735	0.34054	0.65538	32	3.3479	0.0026135	0.0099123
"230"	"Endocytosis"	267	-3.415	0.95718	1	3.415	0.044055	0.16816	5.4983	1.4463e-05	0.00024437	113	2.9921	0.35883	0.66824	154	4.6766	2.4784e-06	5.9292e-05
"231"	"Endocrine resistance"	92	-0.16511	0.30744	1	0.16511	0.69282	0.87652	3.7375	0.0034726	0.012073	43	3.2604	0.096075	0.37231	49	2.0669	0.01289	0.03506
"232"	"Endocrine and other factor-regulated calcium reabsorption"	48	-0.54041	0.50102	1	0.54041	0.50198	0.75177	-1.4572	0.6904	0.74058	19	0.36189	0.69392	0.87905	29	-2.1677	0.68484	0.7332
"233"	"EGFR tyrosine kinase inhibitor resistance"	78	-1.2984	0.71737	1	1.2984	0.28493	0.52369	4.763	0.00060341	0.0035635	33	3.717	0.033304	0.21886	45	3.0877	0.0026903	0.01008
"234"	"ECM-receptor interaction"	82	-1.1845	0.65651	1	1.1845	0.34409	0.57903	2.5711	0.024987	0.056265	34	2.7404	0.15373	0.45534	48	1.0541	0.050188	0.096349
"235"	"Drug metabolism - other enzymes"	49	-2.3393	0.93155	1	2.3393	0.068235	0.22142	2.2301	0.046852	0.085213	13	3.5922	0.013088	0.14036	35	1.8371	0.029916	0.065173
"236"	"Drug metabolism - cytochrome P450"	64	-7.8161	1	1	9.462	8.6616e-12	9.037e-10	4.1077	0.0019216	0.0075181	18	-0.64666	0.90004	0.97843	45	6.5315	7.4014e-07	2.8773e-05
"237"	"Dorso-ventral axis formation"	25	0.074352	0.35056	1	-0.074352	0.64994	0.84789	0.16281	0.35558	0.43306	13	-0.073797	0.75473	0.8952	12	0.31181	0.24365	0.31055
"238"	"Dopaminergic synapse"	125	2.2638	0.0064287	0.13415	-2.2638	0.99338	1	2.7117	0.01129	0.029947	72	3.3952	0.12473	0.42204	53	0.20715	0.097809	0.1552
"239"	"Dilated cardiomyopathy"	86	3.8139	0.00021233	0.0073844	-3.8139	0.99977	1	2.4701	0.022032	0.050336	49	5.2667	0.0020583	0.042675	36	-0.95846	0.37046	0.4483
"240"	"DNA replication"	34	-7.5966	1	1	7.5966	3.4683e-08	1.8093e-06	6.9819	3.1957e-06	7.6943e-05	5	1.6867	0.17015	0.49455	29	6.8595	9.3225e-07	3.2215e-05
"241"	"D-Glutamine and D-glutamate metabolism"	2	-1.0529	0.77199	1	1.0529	0.22801	0.46032	-0.0041541	0.46011	0.52752	0	NA	NA	NA	2	-0.0041541	0.39318	0.46671
"242"	"D-Arginine and D-ornithine metabolism"	1	0.19326	0.42015	1	-0.19326	0.57985	0.80368	-1.0226	0.68304	0.73722	1	-1.0226	0.86374	0.9589	0	NA	NA	NA
"243"	"Cytosolic DNA-sensing pathway"	49	-4.521	0.99936	1	4.521	0.00063021	0.0097767	3.1261	0.013513	0.034111	11	1.1292	0.3967	0.7097	38	2.9423	0.0035219	0.012036
"244"	"Cytokine-cytokine receptor interaction"	234	-3.6806	0.97718	1	3.6806	0.024084	0.11251	-1.0488	0.41053	0.48125	94	0.24873	0.94197	0.98637	139	-0.86898	0.10159	0.16038
"245"	"Cysteine and methionine metabolism"	45	1.6822	0.043574	0.52456	-1.6822	0.95635	1	1.6188	0.08974	0.13905	26	2.0766	0.24406	0.56784	19	0.062085	0.25181	0.31835
"246"	"Complement and coagulation cascades"	85	-6.3579	1	1	6.3579	4.8255e-06	0.00016782	2.0001	0.036467	0.071339	23	-1.2371	0.96839	0.99349	62	3.0953	0.00081662	0.0040962
"247"	"Colorectal cancer"	59	-2.7423	0.96047	1	2.7423	0.040262	0.15558	4.2582	0.0010154	0.0051333	20	2.7548	0.090877	0.36234	39	3.2647	0.0028809	0.010541
"248"	"Collecting duct acid secretion"	25	-1.2051	0.73757	1	1.2051	0.26529	0.49723	-1.717	0.76825	0.79888	9	-1.1525	0.92566	0.98589	16	-1.2818	0.56249	0.62926
"249"	"Cocaine addiction"	46	0.95426	0.13562	1	-0.95426	0.86355	0.97579	-1.6442	0.72038	0.76175	24	0.25444	0.75029	0.89403	22	-2.6433	0.79861	0.82241
"250"	"Citrate cycle (TCA cycle)"	29	-1.0669	0.67834	1	1.0669	0.32513	0.56852	2.3381	0.040993	0.077566	12	1.8377	0.20805	0.5435	17	1.5097	0.068789	0.12216
"251"	"Circadian rhythm"	29	-0.69856	0.57281	1	0.69856	0.43055	0.68062	3.8318	0.0041627	0.013715	13	2.8333	0.052555	0.2575	16	2.6048	0.018391	0.045763
"252"	"Circadian entrainment"	94	-0.098425	0.27754	1	0.098425	0.72359	0.89519	0.24359	0.25979	0.33463	51	-0.42053	0.95396	0.99225	43	0.81813	0.086965	0.14306
"253"	"Chronic myeloid leukemia"	70	0.13393	0.27973	1	-0.13393	0.72138	0.89519	4.1461	0.001458	0.0063727	31	4.0345	0.014045	0.1409	39	1.9577	0.022696	0.052674
"254"	"Cholinergic synapse"	108	-1.9808	0.82769	1	1.9808	0.17304	0.41174	2.004	0.039384	0.075628	42	2.3058	0.26108	0.57586	66	0.72408	0.057451	0.10648
"255"	"Choline metabolism in cancer"	96	-1.8802	0.81117	1	1.8802	0.19095	0.42961	2.98	0.008338	0.024165	37	2.8016	0.14694	0.43942	59	1.5826	0.018971	0.046456
"256"	"Chemokine signaling pathway"	178	-3.9291	0.9888	1	3.9291	0.012487	0.069418	2.6716	0.0084518	0.02427	71	1.2107	0.73331	0.89139	106	3.2686	0.00026191	0.0018869
"257"	"Chemical carcinogenesis"	90	-8.2862	1	1	9.671	1.0147e-12	1.5881e-10	4.108	0.0014659	0.0063727	22	0.48513	0.68788	0.87905	67	5.4862	9.7745e-06	0.00015199
"258"	"Chagas disease (American trypanosomiasis)"	99	-0.18646	0.32732	1	0.18646	0.67404	0.86466	2.9766	0.010795	0.029129	46	3.127	0.11343	0.40559	53	1.155	0.031088	0.066221
"259"	"Central carbon metabolism in cancer"	61	-3.9374	0.99495	1	3.9374	0.005187	0.038479	5.3247	0.00010931	0.00090313	19	3.1351	0.052184	0.2575	42	4.3084	0.00020606	0.001563
"260"	"Cell cycle"	119	-3.0756	0.9659	1	3.0756	0.035825	0.14376	5.588	4.4268e-05	0.00049485	44	3.752	0.041583	0.24077	75	4.165	4.8262e-05	0.00058027
"261"	"Cell adhesion molecules (CAMs)"	147	-6.1575	0.99998	1	6.1575	2.073e-05	0.00051179	1.7103	0.042784	0.079239	47	-0.33105	0.93525	0.98614	100	2.3005	0.0022053	0.0087928
"262"	"Cardiac muscle contraction"	71	2.0806	0.014342	0.23416	-2.0806	0.98579	1	-0.4133	0.40872	0.48094	38	2.2723	0.25022	0.5722	32	-1.6406	0.53879	0.61155
"263"	"Carbon metabolism"	111	-1.0826	0.58699	1	1.0826	0.41613	0.66117	5.7593	3.317e-05	0.00039931	52	4.2397	0.022077	0.17605	59	3.9194	0.00026695	0.0018869
"264"	"Carbohydrate digestion and absorption"	42	-0.99943	0.64343	1	0.99943	0.36084	0.59962	-0.18806	0.39681	0.47045	16	0.94823	0.48699	0.77431	26	-0.98287	0.43629	0.50819
"265"	"Calcium signaling pathway"	173	-2.3	0.82805	1	2.3	0.17406	0.41174	0.45776	0.16447	0.22982	74	0.82244	0.83507	0.95481	99	-0.10592	0.071453	0.12555
"266"	"Caffeine metabolism"	4	-1.4996	0.86345	1	1.4996	0.13655	0.37492	1.4888	0.14437	0.20921	1	0.64332	0.40532	0.71624	3	1.3476	0.14738	0.21415
"267"	"Butanoate metabolism"	25	1.2115	0.098506	0.93431	-1.2115	0.90058	1	6.5373	1.9618e-05	0.00026697	14	4.9284	0.00073848	0.026128	11	4.2953	0.0018409	0.0076397
"268"	"Breast cancer"	141	-1.2946	0.619	1	1.2946	0.38308	0.61806	2.5155	0.015764	0.03885	55	4.5274	0.016005	0.14731	86	-0.39966	0.11632	0.17733
"269"	"Bladder cancer"	37	0.20985	0.30577	1	-0.20985	0.6945	0.87652	5.6437	0.00010692	0.00090313	19	4.0762	0.0094564	0.12642	18	3.9036	0.0011675	0.0055016
"270"	"Biotin metabolism"	2	0.16106	0.40995	1	-0.16106	0.59005	0.80368	-0.98406	0.69177	0.74058	1	-0.41911	0.73006	0.89139	1	-0.97256	0.66125	0.72157
"271"	"Biosynthesis of unsaturated fatty acids"	27	0.44497	0.25072	1	-0.44497	0.74897	0.90691	4.7837	0.00080576	0.0045037	11	5.2152	0.00036997	0.016437	16	1.89	0.046948	0.091255
"272"	"Biosynthesis of amino acids"	73	-1.5587	0.75385	1	1.5587	0.24987	0.48278	2.049	0.049739	0.088457	31	2.3242	0.20105	0.53902	42	0.70454	0.082926	0.13866
"273"	"Bile secretion"	68	-1.918	0.83297	1	1.918	0.17004	0.4094	2.5213	0.029743	0.061248	27	2.0023	0.26403	0.57826	41	1.6222	0.027743	0.061628
"274"	"Base excision repair"	32	-1.6265	0.8174	1	1.6265	0.18699	0.42961	3.4008	0.0086022	0.024477	11	3.0508	0.042205	0.24077	21	1.99	0.031958	0.067612
"275"	"Basal transcription factors"	41	0.76171	0.16673	1	-0.76171	0.83311	0.96014	1.918	0.070516	0.1145	18	3.22	0.048137	0.2565	23	-0.28779	0.2792	0.34872
"276"	"Basal cell carcinoma"	53	-1.8633	0.84741	1	1.8633	0.15314	0.39218	-0.44141	0.45366	0.52752	19	0.33486	0.70116	0.87905	34	-0.80144	0.34455	0.42302
"277"	"Bacterial invasion of epithelial cells"	66	-0.57424	0.47402	1	0.57424	0.5277	0.76468	2.2612	0.041767	0.077816	27	2.5675	0.13884	0.43942	39	0.80525	0.091609	0.14686
"278"	"B cell receptor signaling pathway"	68	-3.9783	0.9953	1	3.9783	0.0050238	0.038479	5.5945	0.00014333	0.0010682	21	2.9608	0.080356	0.34709	47	4.7502	8.5048e-05	0.00088166
"279"	"Axon guidance"	171	-2.3165	0.85396	1	2.3165	0.15037	0.39218	4.6659	0.00037681	0.0024657	71	3.7103	0.089982	0.36234	100	2.9751	0.00058784	0.0033367
"280"	"Autophagy - other"	30	-1.0075	0.6778	1	1.0075	0.32332	0.56852	0.91637	0.17651	0.24446	14	0.1485	0.71238	0.88274	16	1.1159	0.10973	0.17063
"281"	"Autophagy - animal"	126	-2.9793	0.95336	1	2.9793	0.048889	0.18127	6.9508	6.2376e-07	1.9524e-05	53	3.915	0.042781	0.24077	73	5.796	1.2066e-06	3.4113e-05
"282"	"Autoimmune thyroid disease"	50	-3.4485	0.98597	1	3.4485	0.01564	0.078956	-0.19522	0.3804	0.45444	12	-0.11327	0.75704	0.8952	38	-0.16028	0.20248	0.26812
"283"	"Asthma"	19	-2.7307	0.97126	1	2.7307	0.028679	0.12643	-0.62367	0.53084	0.59303	3	0.099638	0.59329	0.81642	16	-0.72278	0.43419	0.50765
"284"	"Ascorbate and aldarate metabolism"	26	-2.7557	0.96866	1	2.7557	0.031365	0.13448	-1.3909	0.69683	0.74186	4	0.26616	0.52735	0.8072	21	0.12761	0.22558	0.29231
"285"	"Arrhythmogenic right ventricular cardiomyopathy (ARVC)"	70	1.2506	0.07221	0.77937	-1.2506	0.92804	1	1.2765	0.1081	0.16036	32	4.299	0.0060654	0.094316	37	-0.89267	0.36886	0.44811
"286"	"Arginine biosynthesis"	18	0.060284	0.38154	1	-0.060284	0.61901	0.82097	0.53479	0.29171	0.36522	8	0.69157	0.49828	0.78375	10	0.098937	0.28808	0.35803
"287"	"Arginine and proline metabolism"	47	-2.3593	0.93383	1	2.3593	0.067967	0.22142	2.5265	0.039996	0.076334	20	0.49554	0.6708	0.87655	27	2.9069	0.006204	0.018847
"288"	"Arachidonic acid metabolism"	83	-0.29305	0.38443	1	0.29305	0.61704	0.82097	2.1235	0.035254	0.0694	35	3.5299	0.033622	0.21886	48	-0.2219	0.18111	0.24596
"289"	"Apoptosis - multiple species"	30	-1.0422	0.68741	1	1.0422	0.3137	0.55474	-0.65894	0.49817	0.56089	9	0.89075	0.43135	0.7371	21	-1.3707	0.55207	0.62208
"290"	"Apoptosis"	132	-4.4663	0.99758	1	4.4663	0.0025958	0.027083	5.8857	1.7003e-05	0.00024437	49	2.7461	0.19222	0.51983	83	5.3124	4.1399e-06	7.5735e-05
"291"	"Apelin signaling pathway"	136	-1.6331	0.71839	1	1.6331	0.28611	0.52369	3.2806	0.0036321	0.012357	63	2.1708	0.38067	0.69641	73	2.461	0.0031368	0.011213
"292"	"Antigen processing and presentation"	71	-6.1416	0.99999	1	6.1416	5.9537e-06	0.00018635	4.5715	0.00064395	0.0037325	26	-0.26847	0.86616	0.9589	45	5.9463	3.9321e-06	7.5735e-05
"293"	"Antifolate resistance"	29	-0.92047	0.63756	1	0.92047	0.3659	0.59962	2.4834	0.033867	0.06795	12	1.7514	0.22772	0.56388	17	1.7721	0.050767	0.096863
"294"	"Amyotrophic lateral sclerosis (ALS)"	50	-1.2777	0.69896	1	1.2777	0.30742	0.54984	0.15333	0.30136	0.37136	24	-1.1835	0.96479	0.99349	26	1.3497	0.059369	0.10861
"295"	"Amphetamine addiction"	63	2.1447	0.014963	0.23416	-2.1447	0.98504	1	2.1405	0.038494	0.074836	37	2.4069	0.22637	0.56388	26	0.4607	0.1523	0.21827
"296"	"Amoebiasis"	94	-2.9171	0.95126	1	2.9171	0.050079	0.18127	1.5087	0.08132	0.12855	37	0.80286	0.6784	0.87905	57	1.2906	0.028646	0.063183
"297"	"Aminoacyl-tRNA biosynthesis"	43	-1.6851	0.80469	1	1.6851	0.19616	0.42961	2.8409	0.019356	0.045897	18	0.55557	0.64285	0.86176	25	3.2544	0.0062419	0.018847
"298"	"Amino sugar and nucleotide sugar metabolism"	48	-3.9324	0.99533	1	3.9324	0.0053168	0.038479	2.3879	0.031408	0.064204	13	0.94901	0.45094	0.75399	35	2.2181	0.017556	0.044388
"299"	"Alzheimers disease"	160	-3.1901	0.95046	1	3.1901	0.050072	0.18127	2.4127	0.01702	0.041297	70	-0.46975	0.97112	0.99349	90	3.6312	0.00013932	0.001111
"300"	"Allograft rejection"	47	-4.1626	0.99845	1	4.1626	0.0016629	0.019277	-0.75676	0.53587	0.59478	10	-1.0849	0.92411	0.98589	37	-0.28891	0.24555	0.3117
"301"	"Aldosterone-regulated sodium reabsorption"	36	-0.24186	0.44151	1	0.24186	0.5611	0.79468	-0.84605	0.57138	0.63195	12	1.9372	0.18669	0.51774	24	-2.406	0.73879	0.77623
"302"	"Aldosterone synthesis and secretion"	83	-1.9243	0.83487	1	1.9243	0.16855	0.40895	1.8483	0.050669	0.088601	34	1.2567	0.55874	0.8072	49	1.3587	0.035057	0.072327
"303"	"Alcoholism"	177	-2.5621	0.88528	1	2.5621	0.11754	0.34066	-6.4139	0.99925	1	64	0.47272	0.85742	0.9589	107	-3.8531	0.79092	0.82241
"304"	"Alanine, aspartate and glutamate metabolism"	35	-0.9662	0.6697	1	0.9662	0.33365	0.57705	1.0338	0.18431	0.25191	14	0.86804	0.49898	0.78375	21	0.62592	0.14741	0.21415
"305"	"African trypanosomiasis"	32	-3.4445	0.98976	1	3.4445	0.011196	0.064992	0.49923	0.26994	0.34505	12	-1.8681	0.98006	0.99934	20	2.0785	0.027213	0.060887
"306"	"Adrenergic signaling in cardiomyocytes"	140	3.6132	0.00013626	0.0053311	-3.6132	0.99986	1	3.501	0.0044049	0.014214	76	6.3023	0.00025869	0.013409	63	-0.66875	0.21914	0.28635
"307"	"Adipocytokine signaling pathway"	70	0.13721	0.27886	1	-0.13721	0.72224	0.89519	2.4346	0.026263	0.057086	32	3.1702	0.057528	0.27525	38	0.39509	0.12179	0.18298
"308"	"Adherens junction"	70	-2.5432	0.93525	1	2.5432	0.065625	0.21852	3.6967	0.0034258	0.012048	27	2.0905	0.24137	0.56784	43	3.06	0.0040255	0.013318
"309"	"Acute myeloid leukemia"	54	-1.1279	0.66586	1	1.1279	0.33738	0.57705	4.0687	0.0016287	0.0066926	21	3.4826	0.036608	0.22639	33	2.4266	0.011344	0.031785
"310"	"AMPK signaling pathway"	121	0.72674	0.10752	0.96758	-0.72674	0.89247	0.99766	6.78	1.8256e-06	4.7617e-05	62	5.7378	0.0019238	0.042675	59	3.8275	0.00032648	0.0022073
"311"	"AGE-RAGE signaling pathway in diabetic complications"	99	-2.4459	0.90552	1	2.4459	0.096869	0.29726	2.8759	0.01259	0.032568	44	0.75967	0.74199	0.89139	55	3.179	0.001431	0.00645
"312"	"ABC transporters"	44	-5.528	0.99996	1	5.528	4.1619e-05	0.00086845	6.3991	1.5604e-05	0.00024437	14	2.1018	0.16658	0.48873	30	6.3139	1.1329e-06	3.4113e-05
"313"	"2-Oxocarboxylic acid metabolism"	17	-0.11685	0.44192	1	0.11685	0.55935	0.79468	1.932	0.088305	0.13751	7	2.8223	0.042021	0.24077	10	0.15773	0.27606	0.34618
